LVW Advisors LLC Purchases 5,224 Shares of Colgate-Palmolive Company $CL

LVW Advisors LLC raised its position in Colgate-Palmolive Company (NYSE:CL) by 103.1% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 10,292 shares of the company’s stock after acquiring an additional 5,224 shares during the quarter. LVW Advisors LLC’s holdings in Colgate-Palmolive were worth $936,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of CL. Brighton Jones LLC lifted its holdings in Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after acquiring an additional 450 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in Colgate-Palmolive by 4.5% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 266,407 shares of the company’s stock valued at $24,219,000 after acquiring an additional 11,484 shares during the period. 111 Capital bought a new position in Colgate-Palmolive in the fourth quarter valued at about $377,000. MassMutual Private Wealth & Trust FSB lifted its holdings in Colgate-Palmolive by 42.5% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 5,965 shares of the company’s stock valued at $559,000 after acquiring an additional 1,778 shares during the period. Finally, Versant Capital Management Inc lifted its holdings in Colgate-Palmolive by 222.2% in the first quarter. Versant Capital Management Inc now owns 6,060 shares of the company’s stock valued at $568,000 after acquiring an additional 4,179 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.2%

Colgate-Palmolive stock opened at $79.57 on Friday. Colgate-Palmolive Company has a 1 year low of $78.76 and a 1 year high of $104.16. The firm’s 50 day moving average price is $84.19 and its 200-day moving average price is $88.71. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The stock has a market cap of $64.31 billion, a P/E ratio of 22.35, a PEG ratio of 4.14 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the prior year, the business earned $0.91 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, equities analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a dividend of $0.52 per share. The ex-dividend date is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. Colgate-Palmolive’s dividend payout ratio is currently 58.43%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CL. Barclays increased their target price on Colgate-Palmolive from $86.00 to $87.00 and gave the company an “equal weight” rating in a report on Tuesday, July 15th. Citigroup lowered their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research report on Monday, August 4th. Morgan Stanley lowered their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Finally, Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating on the stock in a research report on Thursday. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $97.73.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.